ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $11.77 and traded as high as $16.29. ChronoScale Corporation Common Stock shares last traded at $15.90, with a volume of 415,920 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, ChronoScale Corporation Common Stock currently has an average rating of “Reduce” and a consensus price target of $6.00.

ChronoScale Corporation Common Stock Trading Up 0.8%

The company’s 50-day moving average price is $11.77 and its 200-day moving average price is $8.94. The firm has a market cap of $56.60 million, a price-to-earnings ratio of -2.96 and a beta of 0.86. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its earnings results on Tuesday, April 28th. The company reported ($2.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($2.01). ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The company had revenue of $2.14 million during the quarter, compared to analyst estimates of $4.29 million. Equities analysts expect that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Several institutional investors have recently modified their holdings of the stock. Consolidated Portfolio Review Corp acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $333,000. Citadel Advisors LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $198,000. Geode Capital Management LLC grew its position in shares of ChronoScale Corporation Common Stock by 68.9% in the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after purchasing an additional 10,281 shares during the period. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter valued at about $67,000. Finally, Virtu Financial LLC acquired a new position in ChronoScale Corporation Common Stock during the third quarter worth about $57,000. Institutional investors and hedge funds own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.